Clinical trial
Antagonist of the Glucagon-like Peptide 2 (GLP-2) Receptor
NCT06774807 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antagonist of the Glucagon-like Peptide 2 (GLP-2) Receptor
- Lead sponsor
- University of Copenhagen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- September 7, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy